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ABSTRACT As a model of the protein targets for volatile anesthetics, the dimeric four-a-helix bundle, (Aa2-L1M/L38M)2, was
designed to contain a longhydrophobic core, enclosedby four amphipathica-helices, for speciﬁc anesthetic binding. The structural
and dynamical analyses of (Aa2-L1M/L38M)2 in the absence of anesthetics (another study) showed a highly dynamic antiparallel
dimer with an asymmetric arrangement of the four helices and a lateral accessing pathway from the aqueous phase to the
hydrophobic core. In this study, we determined the high-resolution NMR structure of (Aa2-L1M/L38M)2 in the presence of
halothane, a clinically used volatile anesthetic. The high-solution NMR structure, with a backbone root mean-square deviation of
1.72 A˚ (2JST), and the NMR binding measurements revealed that the primary halothane binding site is located between two side-
chains of W15 from each monomer, different from the initially designed anesthetic binding sites. Hydrophobic interactions with
residues A44 and L18 also contribute to stabilizing the bound halothane. Whereas halothane produces minor changes in the
monomer structure, the quaternary arrangement of the dimer is shifted by about half a helical turn and twists relative to each other,
which leads to the closure of the lateral access pathway to the hydrophobic core. Quantitative dynamics analyses, including
Modelfree analysis of the relaxation data and the Carr-Purcell-Meiboom-Gill transverse relaxation dispersion measurements,
suggest that themost profound anesthetic effect is the suppression of the conformational exchange both near and remote from the
binding site. Our results revealed a novel mechanism of an induced ﬁt between anesthetic molecule and its protein target, with the
direct consequence of protein dynamics changing on a global rather than a local scale. This mechanism may be universal to
anesthetic action on neuronal proteins.
INTRODUCTION
A diverse range of molecules, from structurally featureless
noble gases to complex steroids, can render people into a state
of mind commonly known as general anesthesia. The molec-
ular processes underlying this phenomenon remain unclear
(1–7). Although modulation of neuronal protein functions
through nonspeciﬁc anesthetic perturbation to the lipids in the
central nervous system remains a distinct possibility, the cur-
rent consensus is that anesthetic molecules, despite their struc-
tural diversity, interact speciﬁcally with proteins (5). Extensive
investigations, particularly with biophysics, electrophysiol-
ogy, and mutagenesis approaches, have centered on the hy-
pothesis that anesthetics occupy the hydrophobic pockets or
cavities in the proteins to change the protein function. How
exactly such a change is achieved, however, is still a mystery.
The dimeric protein, (Aa2-L1M/L38M)2, was engineered
by de novo design to create a long hydrophobic core within
a common four-a-helix bundle scaffold (8,9). This four-
a-helix bundle has an anesthetic binding afﬁnity in the anes-
thetizing concentration range of clinical volatile anesthetics
(9,10) and thus is regarded as a suitable model for the protein
targets of general anesthetics. In our Part I article in this issue
(11), we presented the NMR structural and dynamical anal-
ysis of (Aa2-L1M/L38M)2 in the absence of anesthetic
binding. The apoprotein backbone structure was resolved to a
root mean-square deviation (RMSD) of 1.77 A˚. As originally
designed, two monomers of the helix-turn-helix motif form
an antiparallel dimer. The dimeric structure shows that two
helices from the N-terminus to the linker (helix 1 and helix
19) are held together by the ring stacking of F12 and W15
along the hydrophobic core and by a leucine zipper from
complementary pairs of L4, L11, L18, and L25 at the heptad
e position of each monomer. The high-resolution structure
also shows a lateral access pathway near K47 between the
two second helices in the dimer (helix 2 and helix 29) such
that the amphipathic anesthetic molecules can enter the hy-
drophobic core directly from the aqueous phase. Departing
from the initial design, however, is the number of anesthetic
binding pockets identiﬁable within the hydrophobic core.
Whereas the original design intended to create two sites with
mirror images of each other between W15 and M38 of each
monomer (9), the NMR structure suggests only one primary
anesthetic binding site between the aromatic rings of W15 in
the dimer, and two possible minor binding sites between the
ring stacking of F12 and F52 (11).
In this study, we experimentally measured the halo-
thane binding to (Aa2-L1M/L38M)2 and determined the
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high-resolution structure of (Aa2-L1M/L38M)2 in the pres-
ence of halothane. Comparison of the structures and dy-
namics of (Aa2-L1M/L38M)2 in the presence and absence of
a bound halothane molecule revealed an interesting change in
protein quaternary structure and in the overall dynamics of
the protein. These results shed new light on how volatile
anesthetics might potentially produce functional changes in
proteins in general.
MATERIALS AND METHODS
(Aa2-L1M/L38M)2 expression and puriﬁcation, NMR sample preparation,
and all NMR methods for structure determination have been described in
detail in Part I (11). Brieﬂy, the conventional suite of two-dimensional (2D)
and three-dimensional (3D) heteronuclear, ﬁltered experiments for spectral
assignment, TALOS dihedral angle constraints, and NOESY distance con-
straints were carried out using the standard pulse sequences from the Bruker
sequence library. 15N- and 13C-ﬁltered NOESYwas measured with a mixing
time of 120 ms. The NOESY assignment was done initially using the Cyana
program (12) and then improved manually. Because of the high helical
content in (Aa2-L1M/L38M)2 and the characteristic short- and mid-range
NOE connectivity to deﬁne the helix regions in the structure, the long-range
intersubunit NOEs from residues on the opposite ends of the helices can be
distinctively and positively identiﬁed by the chemical shift matching with an
exclusion strategy, without resorting to mixing labeled and unlabeled sam-
ples and using speciﬁc ﬁltering or purging pulse sequences. In the halothane
titration experiments, the (Aa2-L1M/L38M)2 concentration was 500 mM in
10%D2O/90%H2O with 0.4% 2,2-dimethyl-2-silapentane-5-sulfonic acid
(DSS) and 0.02% NaN3. Neat halothane was added in 0.3 ml increments
using a Hamilton microsyringe. Because evaporation during the repeated
titration procedure could not be controlled, the halothane concentrations in
the NMR sample were measured by the halothane 1H intensities after each
titration step and then calibrated against the ﬁnal titration point, at which both
1H and 19F intensities were measured, with the 19F intensity calibrated
against known concentrations of triﬂuoroacetate solutions (13,14). Based on
this calibration, the halothane concentrations in the titration experiment
ranged from 0 to 2.2 mM, at which point the chemical shift change started to
plateau. At very low halothane concentrations, the halothane peak was too
weak to be accurately measured. This technical difﬁculty prevents the site-
speciﬁc Kd values from being accurately quantiﬁed. Therefore, the chemical
shift change as a function of halothane titration is used in this study only as a
qualitative indication of the halothane binding site(s). To estimate the
magnitude of Kd at the binding site, nonlinear regression with the following
equation (15,16) was used to ﬁt the chemical shift changes as a function of
halothane concentration, including the point with zero halothane:
Dobs ¼ Dmax
2½P0
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 

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q 
; (1)
where [A]0 and [P]0 are the anesthetic and protein concentration, respec-
tively, and Dmax is the limiting chemical shift difference.
Except for temperature dependent amide proton exchange measurements,
for which HSQC experiments were performed at 25, 30, 35, and 40C to
determine the temperature coefﬁcient for hydrogen bonding constraints, all
other NMR experiments were conducted at 35C. Most of the NMR ex-
periments were carried out using a Bruker Avance 600 spectrometer. For
selected experiments, Avance 700 and 800 spectrometers were used.
Two different types of experiments were conducted to determine the
halothane binding to (Aa2-L1M/L38M)2 by measuring the intermolecular
NOE. The conventional 2D 1H-1HNOESYwas used to measure the coherent
NOE build-up, whereas selective saturation transfer was used to measure the
noncoherent cross relaxation between the two interacting molecules. The 1H
saturation transfer NOE experiments used tr-HSQC-based pulse sequence.
Selective saturation of halothane proton resonance was achieved using an
IBURP2 pulse train (80-ms shaped pulses with an interpulse delay of 4 ms
and a total duration of 1.6 s) preceding the tr-HSQC sequence. Interleaving
on-resonance and off-resonance (–5000 Hz) spectra were acquired to de-
termine the saturation-transfer effects between halothane and individual
residues.
The halothane effects on backbone dynamics were measured in the
presence of 2.2 mM halothane and compared with the results obtained
without halothane as described in Part 1 (11). The 15N R1 and R2 relaxation
and 15N-{1H} heteronuclear NOE (hetNOE) data were analyzed using the
Lipari-Szabo model-free approach (17,18) with the Modelfree program (19).
The R2 relaxation dispersion spectra were acquired at 35C on Bruker 800
MHzNMR spectrometers with 15N operating frequencies of 81.09MHz. The
spectra were recorded with 1024 t2 and 128 t1 data points, with spectral
widths of 10 ppm for 1H and 24 ppm for 15N dimensions. The relaxation-
compensated constant-time Carr-Purcell-Meiboom-Gill (CPMG) sequence
was used (20,21). The total CPMG constant-time delay was set to TCPMG ¼
60 ms (two 30 ms CPMG periods). The spectra were collected with 10 dif-
ferent CPMG ﬁeld strengths, measured by nCPMG of 33.33, 66.67, 100.00,
133.33, 200.00, 266.67, 333.33, 400.00, 500.00, and 666.67 Hz, where
nCPMG ¼ 1/(4tCPMG), and the separation between the centers of successive
refocusing 180 pulses equals 2tCPMG. An additional reference spectrumwas
collected by removing the CPMG periods in the pulse sequence. A relaxation
delay of 2.5 s was used. The 1H chemical shifts were referenced to DSS
resonance at 0 ppm, and the 15N chemical shifts were indirectly referenced
(22).
To analyze transverse relaxation dispersion, the intensities of crosspeaks
in 2D R2 relaxation dispersion spectra with a given CPMG ﬁeld strength
were measured and then converted into the 15N transverse relaxation rate
constant R2 and associated uncertainties according to the well-established
relations (23):
R2ðnCPMGÞ ¼  1
TCPMG
ln
IðnCPMGÞ
I0
 
(2)
and
dR2ðnCPMGÞ ¼ 1
TCPMG
dIðnCPMGÞ2
IðnCPMGÞ2
 
1
dI
2
0
I
2
0
 	 
1=2
; (3)
where I(nCPMG) and I0 are the intensities for a given crosspeak, and
dI(nCPMG) and dI0 are the noise levels in the dispersion spectra with and
without the CPMG pulse trains, respectively. Three exchange parameters,
R20, Fex/kex and kex were calculated using the fast exchange limit approx-
imation (Dv ¼ va  vb , kex) with two exchanging sites to ﬁt the R2
dispersion proﬁle R2(nCPMG) by (24):
R2ðnCPMGÞ ¼ R201Fex
kex
1 4nCPMG
kex
tanh
kex
4nCPMG
  
; (4)
in which R20 is the R2 without exchange (in the limit of nCPMG ¼N),Fex ¼
(va  vb)2papb, pi and vi are the populations and Larmor frequencies for the
nuclear spin in site i; and kex is the exchange rate. It should be noted that kex
describes exchange rate on the ms-ms timescale and is not the same as the
phenomenological Rex term used in the Modelfree approach (24,25).
RESULTS
Site-speciﬁc anesthetic binding
Two independent NMR methods were used to determine
possible site-speciﬁc interactions between anesthetics and
(Aa2-L1M/L38M)2. The ﬁrst was an anesthetic titration ex-
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periment, in which the dependence of chemical shifts of in-
dividual residues in (Aa2-L1M/L38M)2 was measured as a
function of halothane concentration. Fig. 1 A depicts the
representative overlaps of HSQC contour plots for four res-
idues where the backbone amide 1H or 15N chemical shifts
are profoundly affected by varying concentration of halo-
thane. Nonlinear ﬁtting with Eq. 1, including the point
without halothane, yield an estimate of Kd atW15 to be 2.66
1.7 mM (R2 ¼ 0.996). To visualize the overall halothane
effects on HSQC chemical shifts, the normalized changes in
the weighted average of the 1H and 15N chemical shifts with
and without 2.2 mM halothane are color coded onto the
protein structure (see below for structural determination), as
shown in Fig. 1 B. Clearly, the most sensitive region is near
W15. To further conﬁrm that the concentration-dependent
chemical shift changes are indeed a result of halothane
binding instead of other nonspeciﬁc effects, a second, inde-
pendent NMR method was used to measure the saturation
transfer (26) between halothane and various residues. The
percentage change in tr-HSQC peak intensity from the sat-
uration transfer difference spectroscopy is mapped on the
structure (Fig. 1 C), showing again the speciﬁc interaction
between halothane and the protein near W15, A22, and A44.
Neither chemical shift titration nor the saturation transfer
difference spectroscopy showed signiﬁcant halothane effects
on M38, conﬁrming the prediction from a computer simu-
lation (27) and our own structural study (Part I (11)) that M38
is not directly involved in the halothane binding. Thus, the
3.5-fold enhancement in the halothane binding afﬁnity due to
L38M mutation must result from allosteric effects.
High-resolution structures with a
bound halothane
Parallel to the studies without anesthetics as described in Part
I (11)), the same batch of the expressed proteins was used in
this study to determine the (Aa2-L1M/L38M)2 structure in
the presence of halothane. The same suite of heteronuclear,
multidimensional NMR experiments was performed for as-
signment and structure determination. The NOE connectivity
and chemical shift index (CSI) pattern resemble those shown
in Fig. 3 of Part I (11)). Again, two helical segments, from R5
to E27 and from E36 to R58, are readily identiﬁable in the
NOE connectivity and CSI. The two termini and the glycine
linker between the two helices appear to be unstructured
based on the CSI and dynamics results (see below). The
statistics of the 20 structures with the lowest target function is
given in Table 1. The overall backbone RMSD is 1.72 6
0.39 A˚; the backbone RMSD of the helical regions is 1.056
0.28 A˚. The insigniﬁcant difference in RMSD between the
apo- and halothane-bound protein structures is likely due to
the difference in the spectral quality and the different num-
bers of total constraints available for the structural calcula-
tion. In the presence of halothane, at least two intermolecular
NOE peaks were positively identiﬁed in 2DNOESY between
halothane and L18 and A44 (Fig. 2). Structural calculations
with the inclusion of a halothane molecule clearly deﬁne the
halothane binding pocket, which is shown to be bordered by
the aromatic side chains of W15 and the hydrophobic side
chains of L18 and A44 in the dimeric form (Fig. 3 E). Fig. 3,
A and B, show the superposition of the structures with and
without halothane in the monomer and dimer forms, re-
spectively, exhibiting nearly the same secondary and tertiary
monomer structures and pronounced quaternary structural
changes after the addition of halothane. The side-chain ar-
rangements surrounding the primary halothane binding site
FIGURE 1 Halothane binding to the four-a-helix bundle (Aa2-L1M/
L38M)2. (A) Overlap of HSQC contour plots for residues F12, E14, W15,
and A44 in response to halothane titration, which was done by adding neat
halothane to the NMR sample in 0.3-ml increments. The same contour scale
is used for all peaks in each plot to show relative intensities. The peak colors
in the order of red, orange, green, blue, and purple indicate increasing
concentrations of halothane from 0 to 2.2 mM. In the contours for W15 and
A44, the shifted A44 peaks (blue and purple) overlap with the unshifted
W15 peak (red). Notice that W15 shows a large chemical shift jump at the
ﬁrst titration point and greatly increased intensities at higher halothane
concentrations. (B) Individual residues in the NMR-determined structure are
color-coded according to their normalized chemical shift sensitivities to
halothane titration, with blue to red representing the least to most sensitive,
respectively. (C) Normalized saturation transfer NOE is mapped onto the
NMR structure of (Aa2-L1M/L38M)2 using the blue-white-red color code.
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without and with a bound halothane are depicted in Fig. 3, C
and D, respectively, and the packing details of halothane
interaction with the protein at the binding site are shown in
Fig. 3 E. Whereas the halothane orientation in the pocket is
not ﬁxed, there is a clear orientation preference in binding
interaction in the bundle of structures (Fig. 4) because of
cation-pi type of interaction between the partial positive
charge on the hydrogen atom of halothane (28) and the aro-
matic ring of W15. Among the 20 lowest-energy structures,
12 have a halothane orientation as shown in Fig. 3 E, with
halothane’s Br and Cl each interacting with one of the two
hydrophobic side chains of L18, and the hydrogen and the
–CF3 moiety orienting toward the W15 aromatic ring and the
A44 side chain, respectively. In the remaining 8 structures,
the halothane ﬂips;180 to point the proton to the aromatic
ring of the other W15.
FIGURE 2 A contour plot of a 1H-1H 2D NOESY spectrum showing
unambiguous crosspeaks between halothane resonance at;6.4 ppm and the
side chains of L18 and A44.
FIGURE 3 Comparison of high-resolution NMR structures of (Aa2-L1M/
L38M)2 determined with and without halothane. (A) The monomer structure
determined in the presence of halothane (purple) is superimposed onto the
structure of the apoprotein (yellow). (B) Superposition of the dimer struc-
tures. Notice the quaternary structural changes and supercoiling of the
helices in the presence of halothane. (C) Side view of hydrophobic core of
the four-a-helix bundle in the absence of halothane. (D) Side view of
hydrophobic core of the four-a-helix bundle with a halothane bound in the
primary binding site. (E) Detailed interactions between halothane and the
residues surrounding the anesthetic binding pocket. In C, D, and E,
important side chains are shown in licorice representation: W15 (orange);
K47 (cyan); E43 (pink); F12 (green); and A22 and A44 (lime). The
halothane molecule is shown in VDW spheres: C (cyan); H (white); Cl
(blue); Br (red); and F (pink).
TABLE 1 Structural statistics of 20 (Aa2-L1M/L38M)2 structures
with halothane
NMR structure Statistic
Restraints per monomer
NOE distances
Intraresidue 144
Short range (i-j ¼ 1) 128
Medium range (1, i-j # 4) 96
Long range (i-j . 4) 15
Dimer (intermonomer) 6
Dihedral angles 72
Hydrogen bonds 20
Residual upper limit constraints violations number
. 0.5 A˚
0
Residual dihedral angle constraints violations
number . 5
0
Backbone RMSD
Residues 5-27, 36-58, 205-227, 236-258 1.05 6 0.28 A˚
All residues (1-62, 201-262) 1.72 6 0.39 A˚
Heavy atom RMSD
Residues 5-27, 36-58, 206-226, 236-258 1.56 6 0.32 A˚
All residues (1-62, 201-262) 2.07 6 0.36 A˚
Ramachandran plot
Residues in most favored regions 91.0%
Residues in allowed regions 8.9%
Residues in disallowed regions 0.2%
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Anesthetic effects on backbone dynamics
The backbone dynamics was determined by analyzing the R1,
R2, and hetNOE of the backbone amide
15N with and without
halothane using the Modelfree approach (17,18). In addition,
the conformation exchange on the ms-ms timescale was ex-
amined using the CPMG R2 dispersion measurements. The
effects of halothane binding on the local and global dynamics
are depicted in Figs. 5 and 6. Fig. 5 shows the conventional
Modelfree analysis, depicting the generalized order param-
eter, the correlation time of the fast local motion (te), the
exchange contribution to the relaxation (Rex) (29), and the
model number used to ﬁt the data. As in the case without
anesthetics, the two termini and the loop regions are signif-
icantly more ﬂexible, with order parameters lower than 0.5.
The loop region does not meet the basic Lipari-Szabo as-
sumption and can only be ﬁtted with Model 5. In the presence
of halothane, the residues in the immediate vicinity of the
binding site showed slightly elevated order parameters, be-
coming more ordered than without halothane. The most
profound changes are seen in the global distribution of the
Rex term in the helical regions. Overall, Rex is reduced upon
halothane binding, suggesting a lesser degree of conforma-
tional exchange. The involvement of nonzero Rex terms in
many residues is conﬁrmed by the R2 dispersion measure-
ments, which are independent of the model selection or the
spectral density mapping. As shown in Fig. 6, many residues
exhibit the R2 dependence on the CPMG frequencies. The
DR2 values, which are estimated from the R2 values at the
two extreme CPMG frequencies achievable with our NMR
hardware, display the same distribution pattern as Rex along
the protein sequence (Fig. 6 B). It should be noted that the
DR2 measured by the relaxation dispersion underlies the
phenomenological nonzero Rex term in the Modelfree anal-
ysis, albeit the two are not expected to be identical (25) be-
cause the two experimental methods are sensitive to motions
on different timescales. Nevertheless, the overall trend is
clear, and the binding of halothane reduces the conforma-
tional exchange on the global scale. The signiﬁcance of this
reduction in Rex (or DR2) will be discussed below. As in the
case without halothane, two residues, M38 and C41, still
show a larger Rex than other residues, albeit halothane re-
duced the Rex values by a factor of 2. Exchange parameters,
R20, Fex/kex, and kex, determined for several residues using
the fast exchange limit approximation (Eq. 4) to ﬁt the
R2 dispersion data, are shown in Supplementary Material,
Table S1. There seems to be also a slight tendency that hal-
othane binding makes the loop region more ordered as shown
in the S2 values. This is supported by the slightly elevated R2
values for some of the loop residues in the R2 dispersion
measurements (e.g., G30 in Fig. 6 A). However, since the R2
dispersion method is prone to artifacts when R2 is not sig-
niﬁcantly larger than R1 (30), which is indeed the case for the
loop residues, the small difference in the R2 dispersion with
and without halothane should be taken with caution for the
loop and terminal residues. Using the same method as in Part
FIGURE 4 Orientations of halothane molecules in the binding pocket. A
bundle of 20 halothane molecules (C-C bond (cyan); C-H bond (white) is
depicted in relation to the bundle of W15 side chains (orange) in the 20
lowest energy structures. Although the halothane orientation is not ﬁxed, the
hydrogen, with partial positive charge, has the tendency to point to the
aromatic ring of W15 due to cation-pi type of interaction.
FIGURE 5 Comparison of (Aa2-L1M/L38M)2 dynamics in the presence
and absence of halothane binding. (A) The squared order parameter (S2), (B)
the local correlation time (te), (C) the exchange contribution (Rex), and (D)
model number used in the model-free analysis are plotted as a function of the
residue numbers of the four-a-helix bundle, depicting the dynamics in the
absence (s) and presence (d) of 2.2 mM of halothane. Notice that halothane
stabilizes overall protein motion as evidenced by the increased S2 in the
immediate vicinity of W15 and the globally reduced Rex terms at many
residues.
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I (11) to search for the best-ﬁtted tm value, the Modelfree
calculations yielded the global tumbling time of 5.006 0.08
ns, in agreement with the global tumbling time of the apo
protein.
DISCUSSION
Primary anesthetic binding site in the
four-a-helix bundle
Four-a-helix bundle is a common scaffold found in many
important functional proteins. For example, the transmem-
brane domains of anesthetic-sensitive superfamily of Cys-
loop receptors are composed of pseudosymmetric pentamers
of four-a-helix bundles. Serving as a model for anesthetic
protein targets, (Aa2-L1M/L38M)2 was designed with a few
iterations of design changes aimed at improving the binding
afﬁnity for volatile anesthetics (8,9). Our structural studies of
(Aa2-L1M/L38M)2 in the absence of a bound anesthetic, as
detailed in Part I (11) suggested a primary binding site be-
tween the twoW15 side chains in a dimer and an amphipathic
lateral access pathway from the aqueous phase through the
ﬂexible C-terminal helix interface into this binding site.
These ﬁndings are somewhat unexpected because the in-
tended binding sites by design are closer to the two ends of
the hydrophobic core of the four-helix bundle, and thus there
should be two sites that are mirror images of each other. In the
present structural study with halothane, we conﬁrmed that the
main halothane binding site is indeed sandwiched between
the two W15 residues. The chemical shift changes in re-
sponse to titration with varying concentrations of halothane,
the saturation transfer experiment, and 2D NOESY experi-
ment all indicate that the preferred halothane interaction site
are in the middle section of the four-helix bundle, instead of
between W15 and M38 as the latest iteration of design had
intended. The apparent dissociation constant for halothane
binding to (Aa2-L1M/L38M)2 is estimated to be in the
submillimolar range based on the ﬂuorescence quenching on
(Aa2-L38M)2 (9). Our chemical shift titration experiments,
which measure the halothane inﬂuence on the protein back-
bone amide nitrogen and proton chemical shifts, probe the
relative involvement of individual residues in the anesthetic
binding. Since the side chains at the binding site are more
directly involved in the interaction than the backbone, the
site-speciﬁc Kd determined from the backbone chemical
shifts does not necessarily reﬂect the true binding afﬁnity at
the interaction site. Nevertheless, the approximate Kd value
obtained from the chemical shift titration measurements is
consistent with the apparent Kd from the ﬂuorescence
quenching experiments (9).
It is interesting to note that when the experimental struc-
tures were used in a docking search for potential halothane
binding sites, we found that the site between two W15 side
chains is highly preferred (;98%) but not exclusive in the
apoprotein. In contrast, with the lowest energy structure de-
termined in the presence of halothane, Autodock (31) found
the halothane binding site to be exclusively between W15
side chains. The estimated free energy of binding from Au-
todock is –3.35 kcal/mol (4.89 mM), which is in agreement
with the experimental titration data.
An induced ﬁt for anesthetic binding
Detailed structural analysis revealed that the monomeric
helix-turn-helix fold is very similar in the two structural
bundles with and without a bound anesthetic, as shown in
Fig. 3 A. When ﬁtting the helical regions of the monomers,
the RMSD between the two structural bundles is ;1.5 A˚,
which is only slightly larger than the RMSD of the monomers
FIGURE 6 (A) Representative plots of the 15N transverse relaxation rate,
R2, as a function of the CPMG ﬁeld strength, nCPMG, for L4 (e), G30 (D),
M38 (h), C41 (s), and E50 (=) in (Aa2-L1M/L38M)2 without (open
symbols) and with (solid symbols) 2.2 mM halothane at 18.8 T (800 MHz).
Uncertainties in R2 were determined from the signal/noise ratio using Eq. 3.
The R2(nCPMG) dispersion proﬁles for L4, M38, C41, and E50 demonstrate
the contribution of conformation exchange to the 15N transverse relaxation
rate. The solid and dash lines are the best ﬁt to the data for the protein in the
absence and presence of the anesthetic, respectively, using Eq. 4. G30 shows
no conformation exchange and is presented here as a reference. (B) Values of
DR2¼ R2(nCPMG¼33.3Hz) – R2(nCPMG¼ 666.7Hz) are plotted as a function
of residue numbers in (Aa2-L1M/L38M)2 without (s) and with (d)
halothane at 18.8 T. Most residues show a decreased DR2 in the presence
of halothane, indicating that halothane suppresses the global conformational
exchange in the protein.
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among the 20 lowest-energy structures of each bundle. Thus,
halothane binding did not greatly affect the monomer (sec-
ondary and tertiary) structure. As shown in Fig. 3 B, the most
signiﬁcant structural change upon halothane binding is the
quaternary association of the four helices in the dimer. There
is a vertical shift of the monomers relative to each other by
approximately half a helix turn and a super-coil twisting of
the helices when a halothane molecule is bound at the site
between the two W15s. These quaternary structural changes
removed the asymmetry found in the apoprotein due to wider
separation between helix 2 and helix 29. The halothane-in-
duced quaternary changes led to a better ﬁtting between
halothane and the amphipathic cavity of the binding site.
Measured by the Q-SiteFinder program (32), the binding
cavity bordered primarily by the side chains of W15, L18,
and A44 (Fig. 3, D and E) reduces its size from ;381 A˚3 in
the structures without halothane to;162 A˚3 in the structures
determined with halothane (after removing halothane from
the structure). The latter value better matches the molecular
volume of halothane (;130 A˚3 (33,34)). Thus, our structural
data suggest an induced ﬁt between halothane and its binding
site. The high structural ﬂexibility of the apoprotein, the
lateral opening between helix 2 and helix 29 for direct access
to the binding site from the aqueous phase, and the quaternary
structural re-arrangement for an induced ﬁt can all contribute
to an increase in the binding on-rate. As evidenced in the
packing between the halothane molecule and the residues
surrounding the binding pocket (Fig. 3 E), the interaction at
the binding site is both hydrophobic and electrostatic in na-
ture. Optimization of the ﬁtting in the binding site and the
closure of the lateral pathway as a result of the twisting of
helices 2 and 29 relative to helices 1 and 19 will likely de-
crease the binding off-rate, thereby achieving the high-af-
ﬁnity speciﬁc binding of halothane in this designed protein.
Implications of anesthetic effects on local and
global dynamics
In addition to the structural changes, halothane binding to the
four-a-helix bundle also resulted in profound changes in the
protein dynamics, not only locally but also globally at resi-
dues remote from the binding site. This ﬁnding is important
because protein function always involves protein motion.
Thus, the four-a-helix bundle offers more than just a struc-
tural model. The characteristics of halothane effects on the
dynamics of (Aa2-L1M/L38M)2 may have universal impli-
cations on how anesthetic binding to protein ultimately leads
to changes in protein functions (1–3,7,35–37).
In the absence of halothane, (Aa2-L1M/L38M)2 appears
extremely dynamic on the NMR timescale (11). Model-free
analysis showed that many residues in the helical regions
contain the Rex contribution to the backbone amide
15N re-
laxation, suggesting the presence of a conformational ex-
change process at these residues (18,28,38). This ﬁnding is
conﬁrmed in this study by the R2 dispersion measurements.
By comparing the model-free analyses of the relaxation data
with and without halothane as shown in Fig. 5 and of the R2
dispersion data as shown in Fig. 6, it is clear that halothane
binding not only stabilizes the residues in direct contact with
halothane, but also reduces the Rex (orDR2) on a global scale.
The most noticeable Rex changes in (Aa2-L1M/L38M)2 are
atW15 and near M38 and C41. In the apoprotein, W15 signal
is relatively weak (hence precluding the R2 dispersion mea-
surement), presumably due to an intermediate exchange.
Indeed, when the site is not occupied, there is a large degree
of orientation freedom for the W15 side chains within the
hydrophobic core. The NMR structure of the apoprotein
suggests that W15 side chains tend to swing toward F12 to
form an aromatic ring stack within the long stretch of hy-
drophobic core, leaving a large space between the W15 side
chains to accept halothane. When the site is occupied, the two
W15 side chains are locked into a parallel conﬁguration (Fig.
3, D and E) with reduced local ﬂexibility, as indicated by the
increased order parameter at W15 and nearby residues. This
not only changes the chemical shift but also increases the
intensity of W15 in HSQC (Fig. 1 A). One of the direct
consequences of the reduced W15 side chain ﬂexibility—in
addition to the induced ﬁtting for high-afﬁnity halothane
binding as discussed above—is the largest decrease of the Rex
term associated with W15 (Fig. 3 E).
As discussed in Part I (11), another dynamic hotspot in
(Aa2-L1M/L38M)2 is located near M38 and C41. Both of
these residues showed a large Rex term compared to the rest
of the protein when no halothane is bound. It is known that a
point mutation at residue 38 from Leu to Met can result in a
3.5-fold increase in halothane binding. Such an increase
could be due to changes in either structure or dynamics, or
both. Structurally, Leu-Met mutation has been shown to be
well tolerated by numerous studies. Because M38 (or L38) is
not even part of the halothane binding site according to the
NMR structure, local steric effects in a structural sense are
unlikely to be the cause of the increased binding afﬁnity after
the mutation. In searching for other possible explanations, we
believe that global dynamics is an obvious candidate, given
the unusual dynamics property near the mutation site. The
allosteric coupling between W15 and M38 is clearly evident
in the large reduction of the Rex term at M38 and C41 on
halothane binding at W15. This suggests that residue 38 is
situated at a pivotal point to control the global dynamics of
the protein. Although Leu and Met are close on the hydro-
phobicity scale (39), methionine’s side chain is longer and
narrower than leucine’s side chain. Residue 38 is at the ﬁrst
heptad g position in the ﬁrst turn of helix 2 after the ﬂexible
glycine linker. From the apoprotein structure, it can be seen
clearly that the M38 side chain is sandwiched between the
adjacent L37 and the more distant E27 and A23, all of which
congregate at the two ends of the ﬂexible glycine loop. The
long and linear M38 side chain can either point toward the
glycine loop or toward the lateral aqueous phase, depending
on the glycine loop orientation. If L38 resumes the same local
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structure as M38, its side chain has predictably less orienta-
tion freedom relative to the glycine loop due to its bulkier
branching methyl groups. Therefore, it is conceivable that the
mobility at residue 38 in relation to the ﬂexible linker is
critical to the opening and closing of the lateral pathway
between helix 2 and helix 29. The higher halothane binding
afﬁnity found in the L38M mutation can be explained by the
increased on-rate, whereas the off-rate should be dictated by
the W15 ring stacking and induced ﬁt after halothane has
occupied the binding site, which would be similar irre-
spective of L38 or M38.
In support of this viewpoint is the dynamics change at E43
and K47, where sizeable Rex terms can be seen when halo-
thane is absent. After halothane binding, the high-resolution
NMR structures reveal that the quaternary structural changes
shift E43 of one monomer to almost the same level as K47 of
the other monomer. The super-coil twisting brings E43 at
heptad b position closer to K47 at heptad e position of the
opposing helix. The electrostatic interaction stabilizes E43
and closes the interface (and thus the lateral access pathway)
between helices 2 and 29. As a consequence, both E43 and
K47 show a signiﬁcantly reduced Rex term after halothane
binding.
Our results suggest an interesting interplay between
structural ﬁtting and dynamical contribution to anesthetic
binding at protein targets. From a pure structural viewpoint
without considering protein mobility, the space between two
W15 side chains in the apoprotein would not seem ideal for
halothane binding. As discussed above, there is a large dis-
crepancy between the cavity size (381 A˚3) and the volume of
the anesthetic molecule (130 A˚3) for a snug structural ﬁt.
However, the opening between helices 2 and 29 and their
conformational ﬂexibility create an easy access directly from
the aqueous phase to this site. The intrinsic global mobility of
this dimeric protein and the interaction-induced structural
ﬁtting between halothane and the key residues at the binding
site make this site more favorable than other potential sites.
For example, the minor sites found by the Autodock program
in the apoprotein between F12 and F52 would be theoreti-
cally suitable for halothane binding. These minor sites,
however, are not occupied with high afﬁnity due to diver-
gence of the structural and dynamical factors at these sites. As
discussed in Part I (11), the side chain of F52 seems to be
‘‘out of place’’ in the aqueous phase. Although the local
rotational freedom of F12 and F52 side chains would allow
halothane to bind, the absence of a consequent structural
change to secure the binding would render any halothane
occupancy between F12 and F52 short-lived. Similarly,
Q-SiteFinder revealed two amphipathic pockets bordered
mainly by A8, F12, L51, L54, and R58 of one monomer and
L26, E27, L37, M38, and C41 of the other monomer, along
with three residues from the glycine loop. These pockets have
a volume of 303 A˚3 but show no interaction with halothane
experimentally and yield no population by ﬂexible docking.
The controlling factor in this later case is likely to be the
protein dynamics. Thus, when searching for important an-
esthetic interaction site or sites in neuronal proteins to un-
derstand the molecular mechanisms of general anesthesia,
one must analyze and differentiate the structural and dy-
namical contributions to the functional consequences of an-
esthetic-protein interactions.
In conclusion, we identiﬁed a novel anesthetic binding site
in the designed four-a-helix bundle (Aa2-L1M/L38M)2 by
solving its high-resolution structure in the presence of halo-
thane. Different from the designed locations, this site be-
comes preferred over other potential sites, including the two
designed sites, for anesthetic binding after the interaction
between the anesthetic and protein has occurred. The intrinsic
global dynamics characteristics of this protein make the in-
duced ﬁtting possible, and the induced structural ﬁtting upon
anesthetic binding, in turn, modiﬁes the local and global
dynamics of the protein. For neuronal proteins, the latter
aspect is likely to account for functional change of the pro-
teins, ultimately leading to the anesthetizing effects. It should
be pointed out also that we proposed more than a decade ago,
based on the analysis of xenon (6), that some molecules
would not normally be classiﬁed as general anesthetics due to
their lack of basic properties found in common anesthetizing
agents, but they nevertheless can produce anesthesia by
gaining these properties after interactions with their targets
takes place (e.g., induced dipole in xenon). We now show an
example of a related phenomenon, namely, that the protein
targets can be turned into relevant to anesthetic action only
after the interaction between anesthetic and protein has taken
place. The value of the designed four-a-helix bundle as a
model for anesthetic targets lies not only in its structural re-
semblance to the ubiquitous scaffold found in many func-
tional proteins, but also in its dynamics characteristics that
are perhaps more relevant to the functional response to an-
esthetics (1,2).
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